Guidelines and Standards in Chinese Medicine
2023 (1, 1) to Present ISSN: 2837-8792
Sort by
Format:
Per page:
0
results
page
of 0
Country
China
Publisher
Wolters Kluwer
ElectronicLinks
http://journals.lww.com/gscm/pages/default.aspxEditor-in-chief
Aiping Lyu,Yuandong Shen
zhongyijichu7@126.com
Abbreviation
GSCM
Vernacular Journal Title
中医规范与标准(英文)
ISSN
2837-8792
EISSN
2837-8806
Year Approved
2026
Current Indexing Status
Currently Indexed
Start Year
2023
Description
Guidelines and Standards for Chinese Medicine (GSCM) is Sponsored by Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences. It is the first professional journal in China dedicated to the promotion and implementation of standards and guidelines for traditional Chinese medicine (TCM), and also the first English-language journal in the world specifically focusing on research on the standardization of TCM. This journal publishes original research and review papers, as well as specially commissioned articles or authoritative commentaries and newsletters, covering research related to guidelines and standards in the fields of TCM, herbal medicine, acupuncture and moxibustion, homeopathy, complementary and integrative medicine, etc. It aims to provide a high-level, high-quality, and high-impact platform for the scientific development and global dissemination of TCM through in-depth interpretation, academic research, and applied research on TCM guidelines and standards, and to promote the process of standardization, normalization, and internationalization of TCM. We particularly welcome studies including but not limited to: Development and application of clinical practice guidelines, experts consensus, international/ national/ industry/ group/ standards; Quality assessment of published clinical practice guidelines, experts consensus, international/ national/ industry/ group/ standards; New tools/ methods/ methodological issues related to guidelines, consensus or standards; Design protocol, statistical analysis and reporting of clinical researches (randomized/ non-randomized controlled trials/ cohorts/ case-control studies/ case series/ case reports) Basic science research using modern technology and method to explore the mechanism of the disease based on Chinese medicine, complementary and integrative medicine hypothesis and theory; Pharmacy and pharmacology researches with focus on processing, extraction, identification and others to promote the innovation, modernization and application of herbal medicine; Interdisciplinary studies, such as evidence-based public health policy and practice, medical-industrial crossover research.